CHEMICALS AND DRUGS Chemical Actions and Uses [D27] Chemical Actions and Uses Pharmacologic Actions [D27.505] Pharmacologic Actions Molecular Mechanisms of Pharmacological Action [D27.505.519] Molecular Mechanisms of Pharmacological Action Enzyme Inhibitors [D27.505.519.389] Enzyme Inhibitors 5-Lipoxygenase-Activating Protein Inhibitors [D27.505.519.389.086] 5-Lipoxygenase-Activating Protein Inhibitors Acetaldehyde Dehydrogenase Inhibitors [D27.505.519.389.089] Acetaldehyde Dehydrogenase Inhibitors Adenosine Deaminase Inhibitors [D27.505.519.389.092] Adenosine Deaminase Inhibitors Adenylyl Cyclase Inhibitors [D27.505.519.389.108] Adenylyl Cyclase Inhibitors Aromatic Amino Acid Decarboxylase Inhibitors [D27.505.519.389.124] Aromatic Amino Acid Decarboxylase Inhibitors Calcineurin Inhibitors [D27.505.519.389.174] Calcineurin Inhibitors Carbonic Anhydrase Inhibitors [D27.505.519.389.200] Carbonic Anhydrase Inhibitors Catechol O-Methyltransferase Inhibitors [D27.505.519.389.237] Catechol O-Methyltransferase Inhibitors Cholinesterase Inhibitors [D27.505.519.389.275] Cholinesterase Inhibitors Cyclooxygenase Inhibitors [D27.505.519.389.310] Cyclooxygenase Inhibitors Gamma Secretase Inhibitors and Modulators [D27.505.519.389.315] Gamma Secretase Inhibitors and Modulators Glycoside Hydrolase Inhibitors [D27.505.519.389.320] Glycoside Hydrolase Inhibitors Cytochrome P-450 Enzyme Inhibitors [D27.505.519.389.335] Cytochrome P-450 Enzyme Inhibitors Folic Acid Antagonists [D27.505.519.389.350] Folic Acid Antagonists Histone Deacetylase Inhibitors [D27.505.519.389.360] Histone Deacetylase Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors [D27.505.519.389.370] Hydroxymethylglutaryl-CoA Reductase Inhibitors Integrase Inhibitors [D27.505.519.389.375] Integrase Inhibitors beta-Lactamase Inhibitors [D27.505.519.389.400] beta-Lactamase Inhibitors Lipoxygenase Inhibitors [D27.505.519.389.480] Lipoxygenase Inhibitors Monoamine Oxidase Inhibitors [D27.505.519.389.616] Monoamine Oxidase Inhibitors Nucleic Acid Synthesis Inhibitors [D27.505.519.389.675] Nucleic Acid Synthesis Inhibitors Ornithine Decarboxylase Inhibitors [D27.505.519.389.705] Ornithine Decarboxylase Inhibitors Phosphodiesterase Inhibitors [D27.505.519.389.735] Phosphodiesterase Inhibitors Phosphoinositide-3 Kinase Inhibitors [D27.505.519.389.736] Phosphoinositide-3 Kinase Inhibitors Phospholipase A2 Inhibitors [D27.505.519.389.737] Phospholipase A2 Inhibitors Poly(ADP-ribose) Polymerase Inhibitors [D27.505.519.389.739] Poly(ADP-ribose) Polymerase Inhibitors Prolyl-Hydroxylase Inhibitors [D27.505.519.389.740] Prolyl-Hydroxylase Inhibitors Protease Inhibitors [D27.505.519.389.745] Protease Inhibitors Protein Kinase Inhibitors [D27.505.519.389.755] Protein Kinase Inhibitors Protein Synthesis Inhibitors [D27.505.519.389.760] Protein Synthesis Inhibitors Proton Pump Inhibitors [D27.505.519.389.848] Proton Pump Inhibitors Steroid Synthesis Inhibitors [D27.505.519.389.870] Steroid Synthesis Inhibitors Topoisomerase Inhibitors [D27.505.519.389.892] Topoisomerase Inhibitors Uncoupling Agents [D27.505.519.389.936] Uncoupling Agents CHEMICALS AND DRUGS Chemical Actions and Uses [D27] Chemical Actions and Uses Pharmacologic Actions [D27.505] Pharmacologic Actions Physiological Effects of Drugs [D27.505.696] Physiological Effects of Drugs Hypoglycemic Agents [D27.505.696.422] Hypoglycemic Agents Glucagon-Like Peptide-1 Receptor Agonists [D27.505.696.422.125] Glucagon-Like Peptide-1 Receptor Agonists Glycoside Hydrolase Inhibitors [D27.505.696.422.249] Glycoside Hydrolase Inhibitors Amylin Receptor Agonists [D27.505.696.422.374] Amylin Receptor Agonists Dipeptidyl-Peptidase IV Inhibitors [D27.505.696.422.500] Dipeptidyl-Peptidase IV Inhibitors Insulin Secretagogues [D27.505.696.422.625] Insulin Secretagogues PPAR-gamma Agonists [D27.505.696.422.688] PPAR-gamma Agonists Sodium-Glucose Transporter 2 Inhibitors [D27.505.696.422.750] Sodium-Glucose Transporter 2 Inhibitors

Glycoside Hydrolase Inhibitors - Preferred

Concept UI	M000594800
Scope note	Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES.
Preferred term	Glycoside Hydrolase Inhibitors
Entry term(s)	Hydrolase Inhibitors, Glycoside Inhibitors, Glycoside Hydrolase

Pancreatic alpha-Amylase Inhibitors - Narrower

Concept UI	M0587231
Preferred term	Pancreatic alpha-Amylase Inhibitors
Entry term(s)	Inhibitors, Pancreatic alpha-Amylase Pancreatic alpha Amylase Inhibitors alpha Amylase Inhibitors, Pancreatic alpha-Amylase Inhibitors, Pancreatic

Intestinal alpha-Amylase Inhibitors - Narrower

Concept UI	M0587236
Preferred term	Intestinal alpha-Amylase Inhibitors
Entry term(s)	Inhibitors, Intestinal alpha-Amylase Intestinal alpha Amylase Inhibitors alpha-Amylase Inhibitors, Intestinal

alpha-Glucosidase Inhibitors - Narrower

Concept UI	M0587229
Scope note	Compounds that inhibit ALPHA-GLUCOSIDASE.
Preferred term	alpha-Glucosidase Inhibitors
Entry term(s)	Inhibitor, alpha-Glucosidase Inhibitors, alpha-Glucosidase alpha Glucosidase Inhibitor alpha Glucosidase Inhibitors alpha-Glucosidase Inhibitor